Status:
TERMINATED
MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty
Lead Sponsor:
Smith & Nephew Orthopaedics AG
Conditions:
Osteoarthritis of the Knee
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Overall study design: A prospective, randomized, multi-center clinical studies comparing the minimal invasive and the standard surgical total knee replacement technique (control) using the Genesis II...
Eligibility Criteria
Inclusion
- require primary uni- or bilateral total knee arthroplasty; available for 2 year follow up; provide informed consent; is in stable health for cardio-pulmonary conditions.
Exclusion
- inefficient femoral or tibial bone stock; BMI \>35; fixed flexion deformity \>15 degrees; knee flexion of \<90 degrees; varus/valgus deformity \>20 degrees; active local infection; conditions that would compromise the 2 years follow up.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00853398
Start Date
October 1 2004
End Date
December 1 2007
Last Update
May 23 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orthopaedic Department, University Hospital
Tübingen, Germany, 72076